Chart

Quince Therapeutics, Inc.

QNCX

Jan 1 1970 00:00:00

4.02

▲0.4200▲11.67%

Open3.77

High4.23

Low3.77

Close3.60

Volume49.95k

EPS

-1.09

P/E

-3.69

Market Cap

215.93M

Outstanding Shares

53.71M

Soon

Sentiment

Soon

Options

Recent Filings

ID: 0001415889-24-022702

ID: 0001415889-24-022054

ID: 0001415889-24-021869

ID: 0001662774-24-000005

ID: 0001662774-24-000004

ID: 0001104659-24-086395

ID: 0001193125-24-165631

ID: 0001415889-24-016093

ID: 0001415889-24-016092

ID: 0001415889-24-016091

You might find these companies interesting

Springworks Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Champions Oncology, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Tracon Pharmaceuticals, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Jasper Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Cidara Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Silexion Therapeutics Corp

Biological Products, (No Diagnostic Substances) (2836)

10x Capital Venture Acquisition Corp. Iii

Biological Products, (No Diagnostic Substances) (2836)

Meiragtx Holdings Plc

Biological Products, (No Diagnostic Substances) (2836)

Sutro Biopharma, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Adaptimmune Therapeutics Plc

Biological Products, (No Diagnostic Substances) (2836)

Enzon Pharmaceuticals, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Monte Rosa Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Pharmaceutical Preparations (2834)

Vtv Therapeutics Inc.

Pharmaceutical Preparations (2834)